STOCKHOLM, Sweden, May 30, 2002 (PRIMEZONE) -- Today Diamyd Medical is to be listed at Stockholmsborsen's O-list.
"We greet Diamyd Medical welcome to Stockholmsborsen. It is a great pleasure to have one more hightechnology company within the Health Care sector listed at Stockholmsborsen", says Kerstin Hessius, President, Stockholmsborsen.
Diamyd Medical identifies and develops projects within immunology and biotechnology. The company has identified two projects for treatment of autoimmune diseases, diabetes and the neuromuscular disease SMS.
"The listing at the O-list will give Diamyd Medical better conditions for further expansion. We will continue to create shareholder value by developing our business," said Anders Essen-Moller, CEO at Diamyd Medical.
Short name Qty Board lot ISIN code Orderbook ID DIAM B 4 132 039 200 SE0000337917 18765 Global Industry Classification Standard (GICS): Sub-Industry Code Sub-Industry 35202010 Pharmaceuticals Sector Index Index code Index name SX35PI SX35 Health Care_PI SX3520PI SX3520 Pharmaceuticals & Biotechn_PI SX352020PI SX352020 Pharmaceuticals_PI
For further information
Anders Essen-Moller, CEO, Diamyd Medical +46 8 661 00 26 Frank Teneberg, Head of Issuer Sales, Stockholmsborsen +46 70 559 52 75 Maria Andark, Vice President Corporate Communications, Stockholmsborsen +46 70 597 52 76
This information was brought to you by Waymaker http://www.waymaker.net
The following files are available for download:
www.waymaker.net/bitonline/2002/05/30/20020530BIT00200/wkr0001.doc www.waymaker.net/bitonline/2002/05/30/20020530BIT00200/wkr0002.pdf